Propanc Biopharma (PPCB) Return on Assets [ROA] (2011 - 2025)
Propanc Biopharma (PPCB) reported Return on Assets [ROA] of -116.39% for FY2026 (year ended Jun 30, 2026), up 481.69 percentage points from -598.08% in FY2025.
Powered by 
Analysis
Propanc Biopharma (PPCB) Return on Assets [ROA] (2011 - 2025) Analysis & Trends
Dating back to FY2012, Propanc Biopharma's Return on Assets [ROA] record includes 15 fiscal years.
- Return on Assets [ROA] has increased for four consecutive fiscal years, with a five-year change of +3513.72 percentage points (FY2021 to FY2026).
- The FY2026 figure ranks as the highest annual Return on Assets [ROA] in data going back to FY2012.
- According to Business Quant data, Return on Assets [ROA] came in at -598.08% in FY2025 (+2145.89 pp), -2743.97% in FY2024 (+1003.86 pp), -3747.83% in FY2023 (+1862.79 pp) and -5610.62% in FY2022 (-1980.51 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Propanc Biopharma | 550,617.42 | 550,617.42 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -399.36% |
| Sep 30, 2025 | -337.20% |
| Jun 30, 2025 | -279.53% |
| Mar 31, 2025 | -488.46% |
| Dec 31, 2024 | -2,348.86% |
| Sep 30, 2024 | -2,682.13% |
| Jun 30, 2024 | -3,319.04% |
| Mar 31, 2024 | -1,582.84% |
| Dec 31, 2023 | -1,180.79% |
| Sep 30, 2023 | -1,989.32% |
| Jun 30, 2023 | -2,607.50% |
| Mar 31, 2023 | -2,238.04% |
| Dec 31, 2022 | -2,442.37% |
| Sep 30, 2022 | -3,166.17% |
| Jun 30, 2022 | -2,117.06% |
| Mar 31, 2022 | -1,811.16% |
| Dec 31, 2021 | -2,886.58% |
| Sep 30, 2021 | -5,631.61% |
| Jun 30, 2021 | -9,985.57% |
| Mar 31, 2021 | -6,149.50% |
API Access
Propanc Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();